It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for Zuora Inc. (ZUO) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.19, or -2.48%, to $7.47. Volume reached 177,482 shares, with price reaching a high of $7.47 and a low of $7.47. Earlier, Yahoo Finance discussed this stock as it revealed Zuora to Participate in the Jefferies 2022 Office of the CFO Summit.
Zuora Inc. is listed on the NYSE in the Technology sector while operating in the Software – Infrastructure industry. At the end of the last regular session, the stock closed at $7.47 and fluctuated between $7.80 as its day high and $7.36 as its day low. The current market capitalization of Zuora Inc. is $1.02B. A total of 1.11 million shares were traded on the day, compared to an average of 1.08M shares.
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, ZUO has seen 11 BUY and 5 SELL insider trades, representing the acquisition of 191,874 and the disposition of 93,483 shares. Over the last 12 months, there were 68 BUYs and 45 SELLs from insiders. Insiders purchased 2,127,188 shares during that period but sold 1,704,319.
In the most recent transaction, McElhatton Todd sold 10,000 shares of ZUO for 9.56 per share on Jul 11. After the transaction, the Chief Financial Officer now owns 79,185 company shares. In a previous transaction on Jul 01, McElhatton Todd sold 18,136 shares at 8.93 per share. ZUO shares that Chief Financial Officer owns now total 89,185.
Among the insiders who sold shares, Srinivasan Sri disposed of 31,221 shares on Jul 01 at a per-share price of $8.93. This resulted in the Chief Product & Tech Officer holding 69,344 shares of ZUO after the transaction. In another insider transaction, Traube Robert J. sold 21,626 shares at $8.93 per share on Jul 01. Company shares held by the Chief Revenue Officer now total 59,223.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for ZUO in the last 3 months, the mean price target is $16.20 with high estimates of $20.00 and low estimates of $10.00. In terms of 52-week highs and lows, ZUO has a high of $23.25 and a low of $7.40.
As of this writing, ZUO has an earnings estimate of $-0.26 per share for the current quarter. EPS was calculated based on a consensus of 1 estimates, with a high estimate of $-0.26 per share and a lower estimate of $-0.26. The company reported an EPS of $-0.25 in the last quarter, which was -13.64% lower than expectations of $-0.22.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. ZUO’s latest balance sheet shows that the firm has $215.39M in Cash & Short Term Investments as of fiscal 2022. There were $58.76M in debt and $219.30M in liabilities at the time. Its Book Value Per Share was $1.48, while its Total Shareholder’s Equity was $170.61M.
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 5 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ZUO is Overweight with a score of 4.00. A total of 4 analysts rated the stock as Buy while 0 rated it as Overweight while 1 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.